Cancer incidence in persons with Fanconi anemia

Blood

Volumn 101, Issue 3, 2003, Pages 822-826

  Rosenberg, Philip S ^a   Greene, Mark H ^a   Alter, Blanche P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; APLASTIC ANEMIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CALCULATION; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CAUSE OF DEATH; CHILD; CLINICAL FEATURE; CONGENITAL DISORDER; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FANCONI ANEMIA; FEMALE; HAZARD ASSESSMENT; HEAD AND NECK CANCER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; RISK ASSESSMENT; SOLID TUMOR; VULVA CANCER;

EID: 0037306904     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1498     Document Type: Article

References (27)

1. Alter BP, Young NS. The bone marrow failure syndromes. In: Nathan DG, Orkin SH, eds. Hematology of Infancy and Childhood. Philadelphia, PA: Saunders; 1998:237-335.
2. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996;53:99-110.
3. Alter BP. Cancer in Fanconi's anemia, 1927-2001. Cancer. 2003. In press.
4. Young NS, Alter BP. Aplastic Anemia: Acquired and Inherited. Philadelphia, PA: Saunders; 1994.
5. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet. 2001;2:446-457.
6. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002;297:606-609.
7. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7:249-262.
8. Connecticut Tumor Registry. Connecticut Department of Health. http://www.dph.state.ct.us/OPPE/hptumor.htm.
9. Liddell FD. Simple exact analysis of the standardised mortality ratio. J Epidemiol Community Health. 1984;38:85-88.
10. Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GV, Elghetany MT. Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet. 2000;117:125-131.
11. Gaynor JJ, Feuer EJ, Tan CC, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc. 1993;88:400-409.
12. Rosenberg PS. Hazard function estimation using B-splines. Biometrics. 1995;51:874-887.
13. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
15. Cox DR. Regression models and life-tables. J R Stat Soc Series B (Methodological). 1972;34:187-220.
16. Wilcoxon F. Individual comparisons by ranking methods. Biometrics. 1945;1:80-83.
17. Breslow NE, Day NE. Statistical Methods in Cancer Research. Oxford, England: International Agency for Research on Cancer; 1987.
18. Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoracoabdominal irradiation for conditioning. Br J Haematol. 1998;103:249-255.
19. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-629.
20. Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Clinical Oncology. New York, NY: Churchill Livingstone; 2000.
21. Johnson FL, Lerner KG, Siegel M, et al. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet. 1972;2:1273-1276.
22. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999;354:20-25.
23. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
24. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood, 1994;84:1650-1655.
25. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet. 1991;51:1-12.
26. Lensch MW, Rathbun RK, Olson SB, Jones GR, Bagby GC Jr. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Leukemia. 1999;13:1784-1789.
27. Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes (IBMFS). National Cancer Institute. 2002. http://marrowfailure.cancer.gov.